chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe frontal headache, fever, vomiting, pain at injection site. 4/27 same as previous day with taste of metal in mouth, lt arm hard, swollen, hot and red size 6"x 2" very painful to touch. Diarrhea started around 7 AM. Loss of appetite with extreme fatigue. 4/27 around 05:00 PM, I started having copious amounts of clear mucus with congestion in the right middle lobe with expiratory wheeze with a duration of seven hours. The mucus returned with a repeat of the previous night scenario with a six hour duration. On 4/29 around 05:00 AM, my temperature returned to normal and the vomiting ceased. All of my large joints ached and the pain at the injection site reached its peak. On 4/30, only the diarrhea, joint pain, loss of appetite with the taste of metal continued.
shingles; This initial spontaneous report was received on from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medication were not provided.   On an unspecified date in 2014, the patient was vaccinated with a dose zoster vaccine live (ZOSTAVAX) (dosage regimen was not reported) for the long-term prevention of shingles and/or zoster-related conditions.   On an unspecified date, subsequent to patient's dose zoster vaccine live (ZOSTAVAX) inoculation, the patient presented shingles. As a direct and proximate result, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future.  The reporter considered the event of shingles to be related to zoster vaccine live (ZOSTAVAX).
Mother states child rec'vd imm. 8/14/02 4pm and seizured at 9pm 8/15/02. Began to fall, stiffened body, had to shake her to arouse. Parent denies fever during post immuz. time, acted normal played all day without problem. No injuries at time of incident or prior during the day. Taken to ER. Kept overnight for observation at hospital.
Immediately after injection-severe edema erythema to injection site followed by local urticaria. Then was ? Gave Benadryl oral med. Reaction was at DTaP site left thigh.
Vomiting, diarrhea, body aches, headache, sweating and freezing alternatively,
Approximately 20 minutes after receiving vaccine, patient started with scratching on left arm and stomach was churning for about 30 minutes
Monday night -Shoulder pain, felt like whole body was on fire.  Felt exhausted from the pain.  Once fire feeling went away, felt achy all over.   Tuesday and Wednesday had sweats and achy all over.  Shoulder pain moved to neck.  Unstable, kept feeling like was going to fall, felt like couldn't move, body felt heavy.  Worst headache ever, felt like migraine.  Head hurt severly from Tuesday-Wednesday.  Dull ache on Thursday and Friday.  Shoulder and back still hurting (probably about 8 on pain scale.  Took Tylenol on Tuesday night and Wednesday.  Tylenol helped the pain.
problems with pain in her joints; not felt right; pain in the joints and muscles; This spontaneous case was reported by a patient family member or friend and describes the occurrence of ARTHRALGIA (problems with pain in her joints), VACCINATION COMPLICATION (not felt right) and MYALGIA (pain in the joints and muscles) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diverticulitis and Irritable bowel syndrome.   In 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (problems with pain in her joints), VACCINATION COMPLICATION (not felt right) and MYALGIA (pain in the joints and muscles). The patient was treated with IBUPROFEN ongoing since an unknown date for Diverticulitis, at an unspecified dose and frequency; HYDROCODONE ongoing since an unknown date for Diverticulitis, at an unspecified dose and frequency and MELATONIN ongoing since an unknown date for Sleeplessness, at an unspecified dose and frequency. At the time of the report, ARTHRALGIA (problems with pain in her joints), VACCINATION COMPLICATION (not felt right) and MYALGIA (pain in the joints and muscles) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment include blue pill and cream for her stomach diverticulitis.   This case was linked to MOD-2021-363450, MOD-2021-363553 (Patient Link).
36 hours after infection my appendix perforated. Not knowing the cause of my pain, I self-treated for several days before going to the emergency room, where a CT scan revealed an abscess caused by the rupture. I was in hospital for four nights receiving IV antibiotics. I am healing.
started with runny nose, fever, cough.  ended in death due to Upper GI Bleed and inflammatory markers very elevated and no explanation why.
While a very sore shoulder was anticipated and experienced, I also experienced joint pain. Worse, while walking the next day, I had a "hip event", where I suddenly experienced strong pain. Over the last five months, despite reduction in use and having no prior injury or weakness in that area, my condition has only worsened, to where today it is borderline severe, and has limited me to all but basic movement, and that with difficulty.
Patient received Influenza vaccine at 0740, waited in clinic for 15 minutes, then left. 5 minutes later, patient returned and stated that she had begun to experience some swelling of the throat, and numbness to tongue, and felt "shaky".  Patient was taken immediately to treatment room and laid down, and pulse oximetry was established, with initial presentation of 99-100%, and HR of low 100's.  Epi-pen was prepared for usage, and the provider, FNP-C came to evaluate patient.  FNP-C noted clear lung sounds on auscultation, and while speaking to patient also observed that patient did not have any difficulty speaking.  Patient was monitored for approximately 30 minutes, with a gradual decrease from the mild throat swelling to none, and numbness of the tongue to numbness of the back half of the tongue.  On initial screening for the vaccine, patient answered yes to an MSG allergy, and yes to attempting to become pregnant.  The Novartis Fluvirin vaccine was advised by the screening RN.  Clinic staff called to inform patient's supervisor that she would not be returning to work that day.  Patient stated her commute is approximately 15 minutes by driving from this area, so clinic staff administered diphendramine 25 mg PO just before discharge, to time for onset of relief after patient arrived at home.
Experienced syncopal episode; ground level fall; PHN witnessed from vaccination station and provided assistance along with NP on-site. Recipient was lying on side and assisted to supine position; assessed skin pallor, bilateral hands cool to the touch;  denied SOB, denied chest pain; no swelling noted; alert & conversing; stated "I can't hear from my right ear"; d/t fall skull examined and small raised area noted with no skin break. Spanish interpreter utilized.911 called. Denied any h/o of allergies or medical condition; remained alert until arrival of emergency responders. BP taken supine WNL; informed by responders hypotensive standing. Reported hearing returned back to normal. Recipient was taken to local ER for further evaluation. Patient returned to mobile vaccine site after discharge from ED to discuss vaccine and stated ER physician indicated episode was possibly d/t vaccine.
This case was reported by a nurse and described a 33 year old female who did not respond to the hepatitis B vaccine recombinant immunization series. The patient had no relevant medical history. Concurrent medications were not reported. On an unspecified date in 1995, the patient completed a series of Engerix B injections. At an unspecified time post immunization, an unspecified titer revealed that the patient did not have antibodies.
A report has been received from a Pharmacist concerning a 58 year old, Female subject, who had been receiving Nasal FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 20-Oct-2013. It was reported that FLUMIST QUADRIVALENT was administered to a 58 year old patient which started on 20-Oct-2013. FLUMIST QUADRIVALENT (Intranasal) was discontinued on 20-Oct-2013. The outcome of the event of administered FLUMIST QUADRIVALENT to a 58 year old patient is unknown. The report was considered to be non-serious.
Right shoulder swollen, induration 15x15 cm. Tender, red, hot, indurated. Rx for Motrin given and ice area.
sleepy; Back and knee are a little sore; feeling weak; a little headache; Back and knee are a little sore; Arm a little sore from the shot; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old male patient received an unknown dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number; EP6955) via an unspecified route of administration in the left arm on 23Mar2021 at 08:15 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medication, food or other products. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. On an unknown date in Mar2021, the patient experienced little soreness in the arm from the shot, felt weak and sleepy. The patient also had little headache, little sore in back and knee. The clinical outcome of the events pain in arm, weakness, sleepy, headache, sore back and pain knee were unknown at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Fever chills headache muscle aches weakness starting about 12 hours after the shy Also left arm pain swelling and redness at the injection site
Cough  Shortness of Breath  Headache Nasal and Chest Congestion Loss of Taste and Smell
This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (Tested positive for Covid) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for Covid). At the time of the report, COVID-19 (Tested positive for Covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact; Reporter's Comments: Based on reporter's causality the event is assessed as unlikely related to mRNA-1273. Further information has been requested
I had another flare up after the second shot/suspected vaccination failure; I had another flare up after the second shot, but; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: I had another flare up after the second shot/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: I had another flare up after the second shot, but). The outcome of the vaccination failure was unknown and the outcome of the shingles was resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK receipt date: 2-Jul-2023 The case was received from the patient via interactive digital media. The patient had another flare up after the second shot, but his or her physician and the patient knew what it was and immediately started medication, cleared up right away. The patient stated that the shingles was nothing to play around with. This case was considered as suspected vaccination failure since the details regarding the time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Started with increased temp after shot (lasted appx 1 week) was irritable and cried and unable to console unable to lay her down to sleep and had to hold her was checked for strep and neg. Nasal congestion and drainage rash all over symptoms lasted approx 1 week was lethargic - unusual for this child to lay her head down on your shoulder.
Potential Extra Dose/patient and his wife think that he might have had the series maybe 5 years ago; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 72-year-old male patient who received Herpes zoster (Shingrix) (batch number 29GB3, expiry date 16-SEP-2025) for prophylaxis.   Previously administered products included Shingrix (received series on an unknown date).   On 28-OCT-2023, the patient received the 3rd dose of Shingrix. On 28-OCT-2023, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: Potential Extra Dose/patient and his wife think that he might have had the series maybe 5 years ago). The outcome of the extra dose administered was unknown.   Additional Information: Pharmacist reported 72 year old patient was administered a 3rd dose of Shingrix which led to extra dose administered. The patient and his wife think that he might have already had the series maybe 5 years ago, but there was no record of that in the patient's medical record or with his insurance company. The reporter consented to follow up. The vaccine administration facility is the same as primary reporter. The reporter gave permission for follow-up
Intense red rasied rash immediatley following both doses of Moderna. Second dose brought on 10 days of vomiting. Ended up in the ICU for a week with septic shock after immune system went haywire. Emergency stent placement. Mutli-organ involvement brought on by pyelonephritis.  Readmitted to hospital shortly after dischage for failing gallbladder and pancreas.  Culminated in diagnosis of Lupus in February of 2022. Have experienced two additional emergency room visits for inflammation.
pt is a health care provider and desired the vaccine due to her job . 17 years old. When she was called she was told she needed to rtc for second dose after her 18 year birthday. She reported a fever fo 101, sore arm and body aches. Discussed comfort measures today.
Fever, chills, body aches, headache, severe arm and neck pain on side shot was administerd.
I was given the vaccine and a few hours later experienced an inflammatory bowel response which looked like diarrhea, bloating, and gas which is uncommon for me. A bowel movement occured a few hours earlier, around 9am, and was a normal experience. I am unsure what manufacturer produced the vaccination but it was administered by local HHS.
WENT TO BED AT 12PM - WITHIN MINUTES OF FALLING ASLEEP I BEGAN TO SHIVER & MY JAW WAS CLENCHING UNCONTROLLABLY.  WOULD WAKE UP,  RELEASE MY JAW & FALL BACK ASLEEP & IT WOULD HAPPEN AGAIN.  THIS WENT ON ALL NIGHT LONG.  I WOULD RELEASE MY JAW, FALL BACK TO SLEEP & WAKE UP AGAIN & AGAIN WITH A CLENCHED JAW.  I FELT AS IF I WAS IN A TRANCE ALSO.    WOKE UP & MY JAW WAS KILLING ME & MY HEARING WAS MUFFLED IN MY LEFT EAR & VERY PAINFUL.    RIGHT EAR WAS NOT OK EITHER BUT MY LEFT EAR WAS EXTREMELY MESSED UP NEEDLESS TO SAY.  THIS ALL HAPPENED AFTER THE SECOND SHOT ON 6-11-2021.
While driving home,  I had a tinkling up through my left shoulder and into my face resulting in numbness on the left side of my tongue and jaw. It persisted for a solid week. It is mostly better but I still have a strange feeling on the left side of my tongue but not nearly as noticeable as before. I have felt fatigued after this second injection and am still not myself even after three weeks. I am hopeful that this tired feeling subsides as time passes from the injection date.
I had severe nausea and vomiting. I was very sensitive to smells (i.e.: jerk sauce, eggs). I started vomiting every hour from 1:30pm to 7pm the following day, Friday 3/12/21. After my first time vomiting I took two, 25mg MECLIZINE tablets but they did not help.  I could not keep anything down. I tried Water, Ginger Ale, Crackers, and Gatorade.  The all came back up within the hour. It got to the point where I was throwing up foam and green bile because my stomach was empty. I tried to eat again around 10pm and threw up again around 11:25pm. The following day, Saturday 3/13/21, I felt fine when I woke up until I started moving around. I threw up red vomit twice around midday and decided not to eat or drink anything and rest. Later that evening, around 7:30pm, I was able to eat a bland salad that didn't come back up. Today. 3/14/21, I am back to normal but my throat, stomach, and lower back are all sore from vomiting. I would NOT recommend this vaccine or get it again!
my legs were weak /leg gave out; Thighs mostly/upper leg- muscles were achy" /muscle hurting and aching; cant get back up again /could not stand; her leg would not cooperate; This is a spontaneous report from a contactable consumer (patient).   An 83-year-old female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 25Feb2021 17:30 (Batch/Lot number was not reported) as single dose for Covid-19 immunization.  The patient medical history was not reported.  The patient's concomitant medications were not reported.  The patient experienced my legs were weak /leg gave out (limb discomfort) (non-serious) on 27Feb2021 with outcome of unknown , thighs mostly/upper leg- muscles were achy' /muscle hurting and aching (myalgia) (non-serious) on 27Feb2021 with outcome of unknown, can't get back up again /could not stand (dysstasia) (non-serious) on 27Feb2021 with outcome of unknown, her leg would not cooperate (coordination abnormal) (non-serious) on 27Feb2021 with outcome of unknown.    No follow-up attempts are possible; information on Lot/batch number cannot be obtained.
Ached all over; Fatigue; Fever of 102 degrees F; Chills; Head hurt; Threw up; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Ached all over), FATIGUE (Fatigue), PYREXIA (Fever of 102 degrees F), CHILLS (Chills) and HEADACHE (Head hurt) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Ached all over), FATIGUE (Fatigue), PYREXIA (Fever of 102 degrees F), CHILLS (Chills), HEADACHE (Head hurt) and VOMITING (Threw up). At the time of the report, PAIN (Ached all over), FATIGUE (Fatigue), PYREXIA (Fever of 102 degrees F), CHILLS (Chills), HEADACHE (Head hurt) and VOMITING (Threw up) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 102 (High) 102 degrees F.         No relevant concomitant medications were reported. No treatment information was provided. The patient received both scheduled doses of mRNA-1273 prior to the events, therefore, the action taken with the drug in response to the events was not applicable.   This case was linked to MOD21-064660, MOD21-064762 (E2B Linked Report). This case was linked to MOD-2021-061138 (Patient Link).   Reporter did not allow further contact; Sender's Comments:  MOD21-064660: MOD21-064762:
Information has been received from a registered pharmacist concerning a patient who on June 15 2004 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. The reported stated the patient was due for another vaccine intradermally and instead received an intradermal dose of pneumococcal 23v polysaccharide vaccine. Subsequently, the injection site became red and warm. Unspecified medical attention was sought. A product quality complaint was not involved. No further information is expected.
Swollen lymph node left armpit; This is a spontaneous report from a contactable consumer (Patient). A 51-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot Number: Blm0196) via an unspecified route of administration, administered in Arm Left on 18Jun2021 15:00 as single dose for covid-19 immunization at Pharmacy or Drug Store. The patient medical history and concomitant medications was not reported. Previously patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: Blm0176) via an unspecified route of administration, administered in Arm Left on 27May2021 15:00 as single dose for covid-19 immunization. Patient had not Known allergies. The patient experienced swollen lymph node left armpit on 19Jun2021. Patient did not COVID prior vaccination. Patient did not COVID tested post vaccination. No other vaccine in four weeks. Patient had no treatment. The outcome of the event was unknown.   Follow-Up (20Jul2021): Follow-up attempts are completed. No further information is expected.  Follow-Up (05Aug2021): Follow-up attempts are completed. No further information is expected.